Status:
COMPLETED
Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether duloxetine is an effective treatment of attention deficit disorder in adults.
Eligibility Criteria
Inclusion
- Clinical diagnosis of ADHD of at least moderate intensity
- Able to give consent
- Able to swallow capsules
Exclusion
- Allergic or do not tolerate duloxetine
- Under psychotherapy for ADHD
- Taking a medication that interacts with duloxetine, including all psychotropic medication
- Treated with medication for ADHD
- Unstable medical condition
- Severe renal insufficiency
- Liver insufficiency
- Substance/alcool abuse or dependency in the last 6 months
- Pregnancy, nursing or inadequate contraceptive methods
- Suicide or homicide risk
- Organic brain syndrome
- Any diagnosis of lifetime bipolar disorder or psychotic disorder, and any actual diagnosis of anxious disorder or major depressive disorder
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00940693
Start Date
August 1 2009
End Date
December 1 2010
Last Update
December 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Montréal: Hôpital Notre-Dame
Montreal, Quebec, Canada, H2L 4M1